ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY TREATMENT WITH HIGH-DOSE INTERLEUKIN-2

被引:0
|
作者
THOMPSON, JA [1 ]
PEACE, DJ [1 ]
KLARNET, JP [1 ]
KERN, DE [1 ]
GREENBERG, PD [1 ]
CHEEVER, MA [1 ]
机构
[1] UNIV WASHINGTON,SCH MED,DEPT MICROBIOL IMMUNOL,SEATTLE,WA 98195
来源
JOURNAL OF IMMUNOLOGY | 1986年 / 137卷 / 11期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:3675 / 3680
页数:6
相关论文
共 50 条
  • [41] High-dose recombinant interleukin-2/verapamil combination in advanced cancer
    Tagliaferri, P
    Correale, P
    Mottola, M
    deSimone, G
    Montesarchio, V
    Matano, E
    Rea, A
    Morabito, A
    Famiani, M
    Ciardiello, F
    Tortora, G
    Caraglia, M
    Barile, C
    Palmieri, G
    Bianco, AR
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1436 - 1437
  • [42] SELECTING PATIENTS FOR HIGH-DOSE INTERLEUKIN-2 ON THE BASIS OF TUMOUR HISTOLOGY
    Hawkins, R.
    Galvis, V.
    Shablak, A.
    Spencer-Shaw, A.
    Thistlethwaite, F.
    Shanks, J.
    Dalal, N.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 267 - 267
  • [43] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    McDermott, David F.
    [J]. MEDICAL ONCOLOGY, 2009, 26 : 13 - 17
  • [44] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 FOR CHRONIC VIRAL-HEPATITIS
    BACH, N
    SCHAFFNER, F
    LIN, SC
    [J]. LANCET, 1989, 2 (8657): : 281 - 281
  • [45] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    David F. McDermott
    [J]. Medical Oncology, 2009, 26 : 13 - 17
  • [46] High-dose interleukin-2 in metastatic renal cell carcinoma - Reply
    McDermott, DF
    Atkins, MB
    Regan, MM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6798 - 6799
  • [47] INTERLEUKIN-2 AND THE TREATMENT OF LEUKEMIA AND LYMPHOMA
    BRENNER, MK
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 77 - 83
  • [48] Bolus high dose interleukin-2 for the treatment of malignant melanoma
    Pappo, I
    Lotem, M
    Klein, M
    Orda, R
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (03): : 169 - 173
  • [49] High-dose interleukin-2 (HD IL-2) in the treatment of advanced melanoma: The University of Pittsburgh experience
    Davar, Diwakar
    Saul, Melissa
    Tarhini, Ahmad A.
    An Tran
    Trent, Kerry
    Sander, Cindy
    Kirkwood, John M.
    Tawbi, Hussein Abdul-Hassan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Bolus high dose interleukin-2 for the treatment of malignant melanoma
    [J]. Pappo, I. (pappo@cc.huji.ac.il), 2001, Israel Medical Association (03):